help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Licinio-Paixao, J.
Right arrow Articles by Rubenstein, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Licinio-Paixao, J.
Right arrow Articles by Rubenstein, A. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Diabetes Type 1

Journal of Clinical Endocrinology & Metabolism, Vol 63, 401-403, Copyright © 1986 by Endocrine Society


ARTICLES

Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C-peptide

J Licinio-Paixao, KS Polonsky, BD Given, W Pugh, D Ostrega, BF Frank and AH Rubenstein

The validity of C-peptide as a peripheral marker of insulin secretion during different physiological conditions depends on the demonstration that C-peptide clearance is constant under these circumstances. Recently biosynthetic human C-peptide, identical in structure to pancreatic human C-peptide, became available for use in human subjects. The present study was undertaken to determine if the metabolic clearance of C-peptide was altered by ingestion of a mixed meal. Eight insulin-dependent diabetic patients received constant iv infusions of biosynthetic human C-peptide which raised the plasma C-peptide concentration to a level of 3.8 +/- 0.2 (+/- SEM) pmol/ml. The MCR of C- peptide was 4.5 +/- 0.3 ml/kg X min. After steady state levels of C- peptide had been reached, each patient consumed a 530 calorie mixed meal. The plasma glucose concentration increased from a baseline value of 104.5 +/- 4.8 mg/dl to a 336 +/- 10 mg/dl 150 min later. This change in plasma glucose was not associated with a significant alteration in the plasma C-peptide concentration and the MCR of the infused C-peptide was not affected by meal ingestion (4.5 +/- 0.3 vs. 4.3 +/- 0.3 ml/kg X min). These results therefore support the validity of using C-peptide as a marker for changes in insulin secretion after mixed meals.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Erdmann, B. Kallabis, U. Oppel, O. Sypchenko, S. Wagenpfeil, and V. Schusdziarra
Development of hyperinsulinemia and insulin resistance during the early stage of weight gain
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E568 - E575.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, et al.
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve {beta}-Cell Function: Report of an ADA Workshop, 21-22 October 2001
Diabetes, January 1, 2004; 53(1): 250 - 264.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Simon, L. Weibel, and G. Brandenberger
Twenty-four-hour rhythms of plasma glucose and insulin secretion rate in regular night workers
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E413 - E420.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society